“Opioid Crisis: Puerto Rican Drug Distributor Fined Millions – What It Means for Canada”
US Justice Department orders Puerto Rican drug distribution company to pay $12 million fine in opioid case, highlighting the severity of the crisis.
US Justice Department orders Puerto Rican drug distribution company to pay $12 million fine in opioid case, highlighting the severity of the crisis.
Exploring the use of ketamine as a pain treatment in the Canadian opioid crisis despite limited research and regulation, highlighting potential risks and desperate need for alternatives.
The opioid crisis continues with legal action against J M Smith Corporation for alleged unlawful distribution of opioids in the US.
The opioid crisis in Ontario continues to devastate communities, with increased crime, rising homelessness, and strained healthcare systems. Efforts are underway to combat the crisis, including a class action lawsuit against pharmaceutical companies and the widespread distribution of naloxone. However, there is still a long road ahead in addressing this public health issue.
The Canadian opioid crisis has dire impacts on health, safety, and the economy, but efforts for abatement, accountability, and prevention are underway.
The Canadian opioid crisis is a complex problem impacting homelessness, crime, and public health. Various initiatives aim to address this crisis, but a comprehensive approach is needed.
The opioid crisis in Alberta and Calgary is intensifying, with the highest rates of opioid-related deaths on record. Action is needed to address this escalating health emergency.
The Canadian opioid crisis is causing devastating social and health consequences, leading to overdose deaths, homelessness, and crime. Efforts are being made to combat it.
Canada’s opioid crisis continues to worsen, with Alberta, specifically Calgary, recording its highest number of overdose deaths in January 2021. Efforts to combat the crisis, such as naloxone distribution, are ongoing, but a comprehensive and collaborative approach is needed. A new class action lawsuit aims to hold manufacturers and distributors accountable while supporting treatment and prevention services.